Bleeding News and Research

RSS

Trial findings do not support prasugrel monotherapy at the time of primary PCI for STEMI patients

Monotherapy using prasugrel failed to show noninferiority compared with potent antiplatelet therapy plus aspirin at the time of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

29 Aug 2026

Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients

Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after a heart attack.

29 Aug 2026

New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage

Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation who had had an intracranial hemorrhage, according to results presented in a Hot Line session today at ESC Congress 2026.

29 Aug 2026

Researchers identify early molecular warning signs of inflammatory bowel disease

Researchers have uncovered early molecular warning signs of inflammatory bowel disease, revealing the condition can begin before symptoms appear and continue silently even when patients appear well.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 29 Aug 2026

Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk

Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

28 Aug 2026

AI identifies key gene driving aging in blood stem cells

Stem cells possess the unique ability to self-renew and transform into different types of cells. For example, rare hematopoietic stem cells found in bone marrow can become any type of blood cell.

24 Aug 2026

Lancet review examines possible amyloid-beta transmission through blood transfusions

A review and opinion piece published in The Lancet and led by UCL (University College London) and UCLH researchers discusses the possibility that blood transfusions may inadvertently transmit harmful brain proteins, and whether additional safety measures are warranted as a precaution whilst further research is conducted to better understand these potential risks.

21 Aug 2026

Potassium-competitive acid blockers match proton pump inhibitors for preventing bleeding after PCI

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) increases the risk of upper gastrointestinal bleeding (UGIB).

20 Aug 2026

Intravenous iron use among Australian women climbs dramatically over the past decade

The number of Australian women receiving intravenous iron treatments has surged dramatically over the past decade, with new research revealing that one in 20 women of reproductive age received intravenous iron in 2024.

18 Aug 2026

Wearable sensors coupled with AI can non-invasively monitor blood pressure

Wearable sensors coupled with AI can generate blood pressure readings nearly as well as the invasive and risky arterial lines relied on in intensive care units and operating rooms, new work by Johns Hopkins University researchers demonstrates.

17 Aug 2026

Würzburg researchers discover alternative approach to preventing thrombosis

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells, megakaryocytes in the bone marrow.

14 Aug 2026

New ASTRO guidelines optimize radiation therapy for pancreatic cancer

An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.

13 Aug 2026

Modern blood thinners slow cognitive decline in Alzheimer's patients

People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline.

12 Aug 2026

Explainable AI helps predict dangerous bleeding after severe heart attacks

Researchers at Indiana University School of Medicine have developed and tested a six-point scoring system that can help identify patients at high risk of internal bleeding in damaged heart muscle after a severe heart attack using explainable artificial intelligence (XAI).

9 Aug 2026

Experts call for better trials as IVF preparation techniques show unproven results

Preparation techniques used before embryo transfer, considered the most critical step in the IVF process, show no proven effect on pregnancy rates and remain inconclusive due to limited or low-quality data, a new Cochrane review finds.

6 Aug 2026

Review outlines effective approaches to reduce recurrent hepatic encephalopathy

Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality.

31 Jul 2026

URI professor wins $1.5M grant to study cerebral amyloid angiopathy

A $1.5M grant has been awarded to William Van Nostrand, co-executive director of the University of Rhode Island's George & Anne Ryan Institute for Neuroscience and professor of pharmaceutical and biomedical sciences in the URI College of Pharmacy, to study cerebral amyloid angiopathy (CAA), a disease prevalent in the elderly population and commonly found in patients with Alzheimer's disease.

31 Jul 2026

Bleeding News and Research

Trial findings do not support prasugrel monotherapy at the time of primary PCI for STEMI patients

Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients

New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage

Researchers identify early molecular warning signs of inflammatory bowel disease

Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk

AI identifies key gene driving aging in blood stem cells

Lancet review examines possible amyloid-beta transmission through blood transfusions

Potassium-competitive acid blockers match proton pump inhibitors for preventing bleeding after PCI

Intravenous iron use among Australian women climbs dramatically over the past decade

Wearable sensors coupled with AI can non-invasively monitor blood pressure

Würzburg researchers discover alternative approach to preventing thrombosis

New ASTRO guidelines optimize radiation therapy for pancreatic cancer

Modern blood thinners slow cognitive decline in Alzheimer's patients

Explainable AI helps predict dangerous bleeding after severe heart attacks

Experts call for better trials as IVF preparation techniques show unproven results

Review outlines effective approaches to reduce recurrent hepatic encephalopathy

URI professor wins $1.5M grant to study cerebral amyloid angiopathy

Research offers a promising way to develop potent antivenoms against deadly snakebites

Novel interventional approach successfully treats rare hepatic myelopathy

Oral drug avatrombopag reduces chemotherapy treatment delays, trial finds

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News